Form D · Other Technology
Passage Health Inc.
New York, NY · CIK 0001987011
Offering snapshot reported May 13, 2025 · SEC filing
- Reported sold
- $8M Offering amount: $8M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2025 | Initial | $8,000,000 | No comparison | 2 | SEC filing |
| Jul 25, 2023 | Initial | $2,225,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545874
Source: Form D, filed May 13, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gabriel Khaselev | Director, Executive |
| Nicole Naidoo | Director |
| William White | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
66 Frankfort St #4 E
New York, NY, 10038
New York, NY, 10038